As noted in other articles in this issue, benign prostatic hyperplasia (BPH) is a histologic
diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the …

Lower urinary tract symptoms (LUTS) are commonly divided into storage, voiding, and
postmicturition symptoms, and may occur in both men and women. Male LUTS have …

Purpose: To determine the effects of therapy with Urtica dioica for symptomatic relief of lower
urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Material …

Controlled trials that use randomized allocation are the best tool to control for bias and
confounding in trials testing clinical interventions. Investigators must be sure to include …

This paper aims to help healthcare providers better serve patients who are experiencing
nocturia by summarizing current research, clinical approaches, and treatment options. The …

Introduction: This study was undertaken to investigate the effects of pumpkin seed oil alone
or combined with Phytosterol-F on testosterone/prazosin-induced (TP) prostate growth in …

Despite their traditional popularity in many European countries and their increasing use as
dietary supplements in the United States, the role of phytotherapeutic agents in treating …

In Europe, phytotherapeutic preparations have been prescribed for the treatment of
symptomatic benign prostatic hyperplasia (BPH) for over 20 years [l–4]. In these countries …

It has been almost 3 years since the previous re-view of phytotherapeutic agents for benign
prostatic hyperplasia (BPH) by Lowe appeared in Urology. 1 During this period, there has …

The phytotherapeutic agent Serenoa repens is an effective dual inhibitor of 5α‐reductase
isoenzyme activity in the prostate. Unlike other 5α‐reductase inhibitors, Serenoa repens …